Dr. Hsing-Hua Lai

About

Most fertility physicians list what they perform. Dr. Hsing-Hua Lai’s listing is different: none of his three specialties is a standard cycle. Recurrent implantation failure, reproductive immunology, and implantation-phase rescue all describe the same patient — someone who has already done the treatment and did not get a baby from it.

That focus changes how a consultation with him runs. A first failed transfer usually calls for a repeat cycle. A third or fourth calls for a different question: which step broke. His listed work is the audit — retrospectively reviewing uterine cavity and endometrial receptivity, embryo factors and the maternal immune picture, then deciding what changes for the next attempt.

The three items connect in sequence. Immune assessment is the diagnostic layer; implantation-phase rescue is the intervention that follows a transfer, which the clinic says it introduced in 2022 and can begin as early as day 4 after transfer. Because he lists both, the interpretation of the immune result and the timing of the rescue sit with one physician instead of being split across two appointment books — the point where these plans usually fall apart.

He is registered in the clinic’s reproductive medicine group with both Hsinchu and Taipei as practice locations. Hsinchu is where the network began, in 2000; the Taipei campus opened in 2018. He is one of the physicians who work both, so patients in the dual-capital region or the Hsinchu Science Park area can keep monitoring at whichever campus is nearer.

His degree is a dual-major program in Chinese and Western medicine from China Medical University — a curriculum that trains two clinical frameworks in parallel, which fits the environment-and-host angle his work emphasizes.

Clinical Expertise

• Recurrent implantation failure: review of completed cycles in patients with multiple good-quality transfers that did not implant or did not continue, working through uterine cavity conditions, endometrial receptivity, embryo factors and maternal immune status before changing the protocol
• Reproductive immunology and evaluation: immune-side assessment of infertility and early pregnancy loss — reading the mother’s immune profile and the uterine immune environment to set pre-transfer treatment and pregnancy support
• Implantation-phase rescue (IBR): the clinic’s Implanted-Blastocyst Rescue, introduced in 2022 and described on its treatment pages as a set of measures applied around the transfer window to raise the chance of implantation, with the clinic stating that relevant steps can begin from day 4 after transfer

Why Choose Dr. Hsing-Hua Lai

His whole listing points at one hard situation. Reproductive medicine has a well-worn path for first attempts and a much thinner playbook for repeated failures. All three of his specialties sit on the second path, which means his clinic time is spent on cases that need a new hypothesis rather than another cycle of the same one.

Immune diagnosis and rescue timing in one pair of hands. Immune work-up only helps if the blood draw, the medication and the intervention land on the right cycle days, and those days are set by stimulation and transfer scheduling. When the same physician reads the immune result and decides the rescue step, the plan keeps its schedule.

Two campuses, so monitoring does not force a move. IVF requires returns on specific days. His practice at both Hsinchu and Taipei gives patients room to attend at the closer site instead of building the cycle around travel.

Credentials

The verifiable personal credential on the clinic’s team page is his dual-major degree in Chinese and Western medicine from China Medical University. His practice category is listed as reproductive medicine; the clinic states the group includes six reproductive medicine physicians.

One caution about the “experience” panel on his clinic profile. The dated entries there — 2000, 2014, 2017, 2018, 2022, 2025, and a planned 2027 opening — are Stork’s corporate milestones (the Hsinchu founding, the gamete bank, PP-IVF, the Taipei campus, IBR, low-carbon egg freezing), not his personal appointments. They predate or exceed any individual career and this page does not treat them as his history.

The clinic does not list his specialist board certification or his assisted-reproduction procedure qualification on his profile card, so neither is claimed here. Its team page also carries his name only in Chinese; the romanization above is a pronunciation guide.

Suitable For

Several good-quality transfers that did not implant: the value of this consultation is finding the broken step, not running the same protocol again. His recurrent implantation failure focus means the file is reviewed against prior cycle records before a plan changes.

Suspected immune causes of infertility or early loss: immune testing has to be timed against stimulation and transfer, so it is best ordered by the physician who will act on it. That is the role his reproductive immunology specialty describes.

Needing a rescue plan around transfer: implantation-phase rescue is time-boxed — it is decided on the transfer day or shortly after, not at a later appointment. Because he lists it, patients at either campus can raise it at the visit where it still applies.

Immune-factor care at the Taipei campus: the Taipei clinic is appointment-only, and first visits require booking in advance through the clinic’s app or phone line.